Association between METS-IR and heart failure: a cross-sectional study.

Background: Prior research has indicated the importance of insulin resistance in the development of heart failure (HF). The metabolic score for insulin resistance (METS-IR), a novel measure for assessing insulin resistance, has been found to be associated with cardiovascular disease (CVD). Nevertheless, the relationship between METS-IR and heart failure remains uncertain. Methods: This cross-sectional study collected data from the 2007-2018 National Health and Nutrition Examination Survey (NHANES). Multivariable logistic regression analysis and smoothing curve fitting were performed to explore the relationship between METS-IR and the risk of heart failure. Subgroup analysis and receiver operating characteristic (ROC) curve analysis were also conducted. Results: A total of 14772 patients were included, of whom 485 (3.28%) had heart failure. We observed a significant positive association between METS-IR and the risk of heart failure in a fully adjusted model (per 1-unit increment in METS-IR: OR: 2.44; 95% CI: 1.38, 4.32). Subgroup analysis and interaction tests revealed no significant influence on this relationship. A saturation effect and nonlinear relationship between METS-IR and heart failure risk were found using a smoothing curve fitting analysis. The relationship was represented by a J-shaped curve with an inflection point at 40.966. Conclusions: The results of our study indicated a J-shaped association between METS-IR and HF in adults in the United States. METS-IR may be a promising novel index for predicting the risk of heart failure. More longitudinal studies are needed to further verify causal relationships and validate the results in different classifications of heart failure populations.

Noble metal nanomaterials for the diagnosis and treatment of hematological malignancies.

BACKGROUND: Recently, the incidence of hematological malignancy, such as various leukemias, multiple myeloma and lymphoma, has revealed an increasing tendency, exhibiting a major impact on human health. Most of the available anti-cancer drugs, however, possess high non-targeted accumulation, dosage-associated toxicity, fast elimination, and lack specificity towards tumors, which restrict their utilization in clinical therapy. This extends also to cancer diagnosis where there is a lack of predictive biomarkers. OBJECT: Noble metal nanomaterials (NM NMs) have the potential to overcome these shortcomings due to several characteristics including ease of synthesis, ultra-small size, easy surface modification and specific physicochemical properties. At present, gold-, silver- and platinum-based nanomaterials have been employed in the tracing and treatment of hematopoietic tumors through direct individual endocytosis or in innovative drug delivery systems (DDS) by conjugation with other targeting biomolecules. PURPOSE: In this mini review, we focus on the use of localized surface plasmon resonance (LSPR)-/surface-enhanced Raman scattering (SERS)- and fluorescence-based diagnosis of NM NMs in the hematological malignancies. Furthermore, the treatment of hematological malignancies utilized the NM NMs or NM NMs-based therapy technology in the chemotherapy, targeted therapy, and photothermal therapy are depicted in depth. The construction of effective and promising NM NMs or NM NMs- dependent theranostic methodology has the potential to provide interdisciplinary knowledge in the development of clinical tracing, diagnosis and treatment of refractory hematological diseases.

The antifeedant, insecticidal and insect growth inhibitory activities of triterpenoid saponins from Clematis aethusifolia Turcz against Plutella xylostella (L.).

BACKGROUND: The diamondback moth, Plutella xylostella (L.) (Lepidoptera: Plutellidae), is a global insect pest of crops, leading to a reduction of agricultural products in productivity and quality. Plant saponins are rich sources for the discovery of candidates to control insect pests. This study focused on discovery of triterpenoid saponins from Clematis aethusifolia Turcz and evaluation of their antifeedant, insecticidal and insect growth inhibitory activities against the 3rd instar larvae of P. xylostella. RESULTS: Seven triterpenoid saponins (1-7) were isolated for the first time from the n-BuOH extract of C. aethusifolia. Monodesmosides 1, 2, and 5 with a free 28-COOH group showed much higher antifeedant activity (DC50 were 733.67-844.77 µg mL-1 at 24 h, and 737.19-748.28 µg mL-1 at 48 h) than bidesmosides 3-4 and 6-7 (DC50 were 1284.35-2053.98 µg mL-1 at 24 h, and 1183.72-1990.96 µg mL-1 at 48 h). Similarly, monodesmosides 1, 2, and 5 (LC50 were 1462.78-1785.96 µg mL-1 ) showed stronger insecticidal activity than bidesmosides 3-4 and 6-7 (LC50 were 2219.22-3050.51 µg mL-1 ) against P. xylostella at 72 h. These results suggest the 28-COOH group is an important functional group for their antifeedant and insecticidal activity. Besides, monodesmosides 1, 2, and 5 showed insect growth inhibitory activity against P. xylostella through reduction of larval growth and percentage of pupation, associated with prolongation of larval and pupal stages. CONCLUSION: The present results provide evidence that triterpenoid saponins from C. aethusifolia, particularly those monodesmosidic saponins with a free 28-COOH group, have the potential to be developed as pesticides to control P. xylostella.

Progress in the Mechanism and Clinical Application of Cilostazol.

Cilostazol is a unique platelet inhibitor that has been used clinically for more than 20 years. As a phosphodiesterase type III inhibitor, cilostazol is capable of reversible inhibition of platelet aggregation and vasodilation, has antiproliferative effects, and is widely used in the treatment of peripheral arterial disease, cerebrovascular disease, percutaneous coronary intervention, etc. This article briefly reviews the pharmacological mechanisms and clinical application of cilostazol.